Estrella Immunopharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -613 | -4,801 | -5,544 | -2,104 |
EBIT | -5,544 | -2,104 | ||
Net Income | -613 | -4,801 | -5,544 | -2,104 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -177 | -727 | -414 | -465 |
Cash | 1,384 | 1,626 | 1,316 | 421 |
Basic Shares | 37,970 | 37,096 | 36,165 | 36,188 |
Annual Financials
| Values in thousands | 2025-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -13,062 | -686 | |
EBIT | -7,310 | -915 | |
Net Income | -13,063 | -7,311 | -996 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1,785 | -16,068 | -1,043 |
Cash | 1,384 | 4,165 | 40 |
Basic Shares | 36,820 | 36,289 | 5,762 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.01 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.15 |
2025-03-31 | -$0.06 |
